Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical options in ulcerative colitis

R Farouk1, J H Pemberton

  • 1Mayo Graduate School of Medicine, Rochester, Minnesota, USA.

The Surgical Clinics of North America
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pouch excision: indications and outcomes.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2017
Same author

Safety, feasibility, and short-term outcomes in 588 patients undergoing minimally invasive ileal pouch-anal anastomosis: a single-institution experience.

Techniques in coloproctology·2016
Same author

What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
Same author

Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.

Alimentary pharmacology & therapeutics·2015
Same author

Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery.

The British journal of surgery·2014
Same author

Simultaneous dyeing and antibacterial finishing for cotton cellulose using a new reactive dye.

Carbohydrate polymers·2013

Ileal length, not pouch shape, determines functional outcomes after ileal pouch-anal anastomosis (IPAA). Ideal pouches use 15-20 cm ileum, and while single-stage IPAA is possible, it

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Colorectal Surgery

Background:

  • Functional outcomes after ileal pouch-anal anastomosis (IPAA) are influenced by surgical technique and patient selection.
  • The management of the anal transition zone (ATZ) and the decision for single-stage versus multi-stage procedures are critical considerations.

Purpose of the Study:

  • To evaluate the impact of ileal length and pouch configuration on functional outcomes after IPAA.
  • To assess the feasibility and indications for single-stage IPAA.
  • To determine optimal management strategies for the ATZ, including mucosectomy and surveillance, in patients undergoing IPAA.

Main Methods:

  • Retrospective analysis of patients undergoing IPAA.
  • Evaluation of functional outcomes based on ileal limb length and pouch configuration.

Related Experiment Videos

  • Assessment of outcomes for single-stage versus multi-stage IPAA procedures.
  • Review of indications for ATZ excision and mucosectomy in specific patient populations (FAP, CUC).

    • Main Results:

    • Ileal length, specifically 15-20 cm, is more critical for functional outcome than pouch configuration.
    • Single-stage IPAA is feasible only in select patients (non-malnourished, no steroids, tension-free anastomosis).
    • Stapled anastomosis does not significantly impact functional outcome but preserves the ATZ, posing risks of neoplasia.
    • IPAA can yield long-term function comparable to benign disease in early-stage cancer patients not requiring radiation therapy.

    Conclusions:

    • Optimal ileal length for IPAA is 15-20 cm.
    • Single-stage IPAA is rarely indicated due to patient selection criteria.
    • Mucosectomy is recommended for all Familial Adenomatous Polyposis (FAP) patients; surveillance is crucial for others with or without mucosectomy.
    • IPAA is a viable option for select early-stage cancer patients not requiring adjuvant radiation.